BioPharma Dive - Latest News

Lilly CEO wields manufacturing plans to push pharma-friendly policies

While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax cuts and changes to Medicare's drug negotiation program.

Feb 26, 2025 - 21:14
 0
Lilly CEO wields manufacturing plans to push pharma-friendly policies

While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax cuts and changes to Medicare's drug negotiation program.

Read More

Tags:

Previous Article

Endo highlights a Xiaflex success story in first branded commercial for Dupuytre...

Next Article

‘Let’s be frank’: Hegseth’s budget shakeup will be ‘painful’ but there’s ‘hope,’...

Related Posts

Mirum drug for rare genetic disease gains FDA approval

Mirum drug for rare genetic disease gains FDA approval

Feb 24, 2025  0

In FDA job cuts, experts see threat of far-reaching impact

In FDA job cuts, experts see threat of far-reaching impact

Feb 20, 2025  0

Axsome secures top drug’s future with Teva patent settlement

Axsome secures top drug’s future with Teva patent settl...

Feb 10, 2025  0